Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 450

1.

A unique insight into the MiRNA profile during genital chlamydial infection.

Benyeogor I, Simoneaux T, Wu Y, Lundy S, George Z, Ryans K, McKeithen D, Pais R, Ellerson D, Lorenz WW, Omosun T, Thompson W, Eko FO, Black CM, Blas-Machado U, Igietseme JU, He Q, Omosun Y.

BMC Genomics. 2019 Feb 18;20(1):143. doi: 10.1186/s12864-019-5495-6.

2.

Non-professional caregiver burden is associated with the severity of patients' cognitive impairment.

Black CM, Ritchie CW, Khandker RK, Wood R, Jones E, Hu X, Ambegaonkar BM.

PLoS One. 2018 Dec 6;13(12):e0204110. doi: 10.1371/journal.pone.0204110. eCollection 2018.

3.

The molecular mechanism of induction of unfolded protein response by Chlamydia.

George Z, Omosun Y, Azenabor AA, Goldstein J, Partin J, Joseph K, Ellerson D, He Q, Eko F, McDonald MA, Reed M, Svoboda P, Stuchlik O, Pohl J, Lutter E, Bandea C, Black CM, Igietseme JU.

Biochem Biophys Res Commun. 2019 Jan 8;508(2):421-429. doi: 10.1016/j.bbrc.2018.11.034. Epub 2018 Nov 28.

PMID:
30503337
4.

Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease.

Ritchie CW, Khandker RK, Pike J, Black CM, Jones E, Ambegaonkar BM.

J Alzheimers Dis. 2018;64(3):899-910. doi: 10.3233/JAD-180306.

PMID:
29966202
5.

Analysis of Episodes of Care in Medicare Beneficiaries Newly Diagnosed with Alzheimer's Disease.

Khandker RK, Black CM, Xie L, Kariburyo MF, Ambegaonkar BM, Baser O, Yuce H, Fillit H.

J Am Geriatr Soc. 2018 May;66(5):864-870. doi: 10.1111/jgs.15281. Epub 2018 Mar 30.

PMID:
29601083
6.

Quantifying the Diagnostic Pathway for Patients with Cognitive Impairment: Real-World Data from Seven European and North American Countries.

Ritchie CW, Black CM, Khandker RK, Wood R, Jones E, Hu X, Ambegaonkar BM.

J Alzheimers Dis. 2018;62(1):457-466. doi: 10.3233/JAD-170864.

PMID:
29439347
7.

Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles.

Sahu R, Verma R, Dixit S, Igietseme JU, Black CM, Duncan S, Singh SR, Dennis VA.

Expert Rev Vaccines. 2018 Mar;17(3):217-227. doi: 10.1080/14760584.2018.1435279. Epub 2018 Feb 6. Review.

8.

Contemporary management of high-grade renal trauma: Results from the American Association for the Surgery of Trauma Genitourinary Trauma study.

Keihani S, Xu Y, Presson AP, Hotaling JM, Nirula R, Piotrowski J, Dodgion CM, Black CM, Mukherjee K, Morris BJ, Majercik S, Smith BP, Schwartz I, Elliott SP, DeSoucy ES, Zakaluzny S, Thomsen PB, Erickson BA, Baradaran N, Breyer BN, Miller B, Santucci RA, Carrick MM, Hewitt T, Burks FN, Kocik JF, Askari R, Myers JB; Genito-Urinary Trauma Study Group.

J Trauma Acute Care Surg. 2018 Mar;84(3):418-425. doi: 10.1097/TA.0000000000001796.

9.

The emerging role of ASC in dendritic cell metabolism during Chlamydia infection.

McKeithen DN, Omosun YO, Ryans K, Mu J, Xie Z, Simoneaux T, Blas-Machado U, Eko FO, Black CM, Igietseme JU, He Q.

PLoS One. 2017 Dec 7;12(12):e0188643. doi: 10.1371/journal.pone.0188643. eCollection 2017.

10.

Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's Disease.

Black CM, Fillit H, Xie L, Hu X, Kariburyo MF, Ambegaonkar BM, Baser O, Yuce H, Khandker RK.

J Alzheimers Dis. 2018;61(1):185-193. doi: 10.3233/JAD-170518.

PMID:
29103033
11.

Molecular Pathogenesis of Chlamydia Disease Complications: Epithelial-Mesenchymal Transition and Fibrosis.

Igietseme JU, Omosun Y, Nagy T, Stuchlik O, Reed MS, He Q, Partin J, Joseph K, Ellerson D, George Z, Goldstein J, Eko FO, Bandea C, Pohl J, Black CM.

Infect Immun. 2017 Dec 19;86(1). pii: e00585-17. doi: 10.1128/IAI.00585-17. Print 2018 Jan.

12.

Second-line treatment persistence and costs among patients with immune-mediated rheumatic diseases treated with subcutaneous TNF-alpha inhibitors.

Dalén J, Svedbom A, Black CM, Kachroo S.

Rheumatol Int. 2017 Dec;37(12):2049-2058. doi: 10.1007/s00296-017-3825-z. Epub 2017 Oct 3.

PMID:
28975392
13.

Small Talk: Identifying communication problems in maltreated children.

Frederico M, Jackson AL, Black CM, Cox A, Joffe B.

Child Abuse Negl. 2018 Jan;75:139-148. doi: 10.1016/j.chiabu.2017.06.009. Epub 2017 Jun 17.

PMID:
28633958
14.

The immunoregulatory role of alpha enolase in dendritic cell function during Chlamydia infection.

Ryans K, Omosun Y, McKeithen DN, Simoneaux T, Mills CC, Bowen N, Eko FO, Black CM, Igietseme JU, He Q.

BMC Immunol. 2017 May 19;18(1):27. doi: 10.1186/s12865-017-0212-1.

15.

Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany.

Sullivan E, Piercy J, Waller J, Black CM, Kachroo S.

PLoS One. 2017 Apr 14;12(4):e0175826. doi: 10.1371/journal.pone.0175826. eCollection 2017.

16.

MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential.

Tigue NJ, Bamber L, Andrews J, Ireland S, Hair J, Carter E, Sridharan S, Jovanović J, Rees DG, Springall JS, Solier E, Li YM, Chodorge M, Perez-Martinez D, Higazi DR, Oberst M, Kennedy M, Black CM, Yan L, Schwickart M, Maguire S, Cann JA, de Haan L, Young LL, Vaughan T, Wilkinson RW, Stewart R.

Oncoimmunology. 2017 Feb 3;6(3):e1280645. doi: 10.1080/2162402X.2017.1280645. eCollection 2017.

17.

Evaluation of a TaqMan Array Card for Detection of Central Nervous System Infections.

Onyango CO, Loparev V, Lidechi S, Bhullar V, Schmid DS, Radford K, Lo MK, Rota P, Johnson BW, Munoz J, Oneko M, Burton D, Black CM, Neatherlin J, Montgomery JM, Fields B.

J Clin Microbiol. 2017 Jul;55(7):2035-2044. doi: 10.1128/JCM.02469-16. Epub 2017 Apr 12.

18.

Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany.

Waller J, Sullivan E, Piercy J, Black CM, Kachroo S.

Patient Prefer Adherence. 2017 Mar 13;11:519-530. doi: 10.2147/PPA.S129333. eCollection 2017.

19.

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line.

Svedbom A, Dalén J, Black CM, Kachroo S.

Patient Prefer Adherence. 2017 Jan 16;11:95-106. doi: 10.2147/PPA.S119808. eCollection 2017.

20.

The Roles of Unfolded Protein Response Pathways in Chlamydia Pathogenesis.

George Z, Omosun Y, Azenabor AA, Partin J, Joseph K, Ellerson D, He Q, Eko F, Bandea C, Svoboda P, Pohl J, Black CM, Igietseme JU.

J Infect Dis. 2017 Feb 1;215(3):456-465. doi: 10.1093/infdis/jiw569.

PMID:
27932618

Supplemental Content

Loading ...
Support Center